Pt Phapros Tbk
PT Phapros Tbk, a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in Semarang, Indonesia. Established in 1954, the company has a rich history marked by significant milestones, including its listing on the Indonesia Stock Exchange. Phapros is renowned for its diverse range of high-quality pharmaceutical products, including prescription medications, over-the-counter drugs, and herbal supplements, all designed to meet the evolving needs of healthcare professionals and patients alike.
With a strong commitment to innovation and quality, PT Phapros Tbk has positioned itself as a trusted name in the Indonesian market. The company’s dedication to research and development ensures that its offerings remain competitive and effective, contributing to its reputation as a leader in the pharmaceutical sector. Through its extensive distribution network, Phapros serves various regions across Indonesia, solidifying its status as a key contributor to the nation's healthcare landscape.
-19 vs industry average
Pt Phapros Tbk’s score of 19 is lower than 11% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pt Phapros Tbk?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 3 accounts for ••• of total emissions.
Pt Phapros Tbk's reported carbon emissions
PT Phapros Tbk, an Indonesian pharmaceutical preparation manufacturer, has reported its carbon emissions for recent years. In 2022, the company's Scope 1 emissions were approximately 0.55 kg CO2e, and its Scope 2 emissions, primarily from purchased electricity, totalled approximately 10,168,000 kg CO2e. For 2021, Scope 1 emissions were around 0.5 kg CO2e, with Scope 2 emissions from purchased electricity at approximately 9,980,000 kg CO2e. In 2020, only Scope 1 emissions data was available, reported as approximately 0.82 kg CO2e. Scope 3 emissions data is not yet disclosed by the company.
PT Phapros Tbk's emissions data is currently cascaded from its corporate family. While specific reduction initiatives and targets for PT Phapros Tbk are not detailed in the provided information, its climate commitments may be influenced by its parent organisation, PT Kimia Farma Tbk, which is indicated as a source for CDP reporting. The company has disclosed data for Scope 1 and Scope 2 emissions in its annual reports.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Pt Phapros Tbk’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Pt Phapros Tbk yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Pt Phapros Tbk
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project